↓ Skip to main content

Gliadel® wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial

Overview of attention for article published in Acta Neurochirurgica, February 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

policy
1 policy source
patent
2 patents

Citations

dimensions_citation
295 Dimensions

Readers on

mendeley
123 Mendeley
Title
Gliadel® wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial
Published in
Acta Neurochirurgica, February 2006
DOI 10.1007/s00701-005-0707-z
Pubmed ID
Authors

M. Westphal, Z. Ram, V. Riddle, D. Hilt, E. Bortey

Abstract

Adjuvant systemic chemotherapy increases survival of primary malignant glioma patients beyond 12-18 months. The only interstitial chemotherapy treatment approved for malignant glioma is Gliadel wafer containing carmustine (BCNU) placed in the resection cavity at surgery. Analysis of a large trial by Westphal and colleagues (n = 240) showed a 29% risk reduction (P = 0.03) in the BCNU wafer-treated group over the course of the 30-month trial. Long-term follow-up of these patients was undertaken to determine the survival benefit at 2 and 3 years.

Mendeley readers

The data shown below were compiled from readership statistics for 123 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Nepal 1 <1%
Australia 1 <1%
France 1 <1%
Brazil 1 <1%
Ukraine 1 <1%
Argentina 1 <1%
Unknown 117 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 32 26%
Researcher 22 18%
Student > Master 13 11%
Other 10 8%
Unspecified 9 7%
Other 37 30%
Readers by discipline Count As %
Medicine and Dentistry 50 41%
Agricultural and Biological Sciences 22 18%
Engineering 11 9%
Unspecified 10 8%
Pharmacology, Toxicology and Pharmaceutical Science 7 6%
Other 23 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 July 2018.
All research outputs
#1,627,862
of 13,205,256 outputs
Outputs from Acta Neurochirurgica
#53
of 1,022 outputs
Outputs of similar age
#26,445
of 191,822 outputs
Outputs of similar age from Acta Neurochirurgica
#2
of 18 outputs
Altmetric has tracked 13,205,256 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,022 research outputs from this source. They receive a mean Attention Score of 3.9. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 191,822 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.